Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;329:1216 (20 November), doi:10.1136/bmj.38238.601447.3A (published 19 October 2004)
Jorge Vas, chief medical officer1, Camila Méndez, epidemiologist2, Emilio Perea-Milla, chief medical officer3, Evelia Vega, chief medical officer7, María Dolores Panadero, pharmacologist2, José María León, professor4, Miguel Ángel Borge, chief medical officer6, Olga Gaspar, nurse1, Francisco Sánchez-Rodríguez, technician5, Inmaculada Aguilar, nurse1, Rosario Jurado, nurse1
1 Pain Treatment Unit, Centro de Salud "Dos Hermanas A" (Distrito Sanitario Sevilla-Sur), 41700 Dos Hermanas, Spain, 2 Distrito Sanitario Sevilla-Sur, Alcalá de Guadaira 41500, Spain, 3 Research Support Unit, Hospital Costa del Sol, 29600 Marbella, Spain, 4 Department of Social Psychology, Universidad de Sevilla, 41018 Sevilla, Spain, 5 Servicio Andaluz de Salud, Servicio de Ordenación Sanitaria, 41001 Sevilla, Spain, 6 Municipal Medical Services, 41927 Mairena del Aljarafe, Spain, 7 Pain Treatment Unit, Centro de Salud "Castilleja de la Cuesta," 41950 Castilleja de la Cuesta, Spain
Correspondence to: J Vas jvas{at}acmas.com
Design Randomised, controlled, single blind trial, with blinded evaluation and statistical analysis of results.
Setting Pain management unit in a public primary care centre in southern Spain, over a period of two years.
Participants 97 outpatients presenting with osteoarthritis of the knee.
Interventions Patients were randomly separated into two groups, one receiving acupuncture plus diclofenac (n = 48) and the other placebo acupuncture plus diclofenac (n = 49).
Main outcome measures The clinical variables examined included intensity of pain as measured by a visual analogue scale; pain, stiffness, and physical function subscales of the Western Ontario and McMaster Universities (WOMAC) osteoarthritis index; dosage of diclofenac taken during treatment; and the profile of quality of life in the chronically ill (PQLC) instrument, evaluated before and after the treatment programme.
Results 88 patients completed the trial. In the intention to treat analysis, the WOMAC index presented a greater reduction in the intervention group than in the control group (mean difference 23.9, 95% confidence interval 15.0 to 32.8) The reduction was greater in the subscale of functional activity. The same result was observed in the pain visual analogue scale, with a reduction of 26.6 (18.5 to 34.8). The PQLC results indicate that acupuncture treatment produces significant changes in physical capability (P = 0.021) and psychological functioning (P = 0.046). Three patients reported bruising after the acupuncture sessions.
Conclusions Acupuncture plus diclofenac is more effective than placebo acupuncture plus diclofenac for the symptomatic treatment of osteoarthritis of the knee.
The role of acupuncture in osteoarthritis of the knee is still a matter of controversy, and few comparative studies of acupuncture and non-steroidal anti-inflammatory drugs (NSAIDs) for its treatment have been conducted.3 A recent systematic review concluded that a moderate degree of evidence exists that the effect of the acupuncture treatment could be due to the placebo,4 and further studies are therefore necessary to determine the true role of acupuncture.
We analysed the efficacy of acupuncture as a complementary therapy to the pharmacological treatment of osteoarthritis of the knee.
We used the following criteria for inclusion in the study: patients had to be aged 45 years or older, with pain in one or both knees for the preceding three months or longer, and with radiological evidence of osteoarthritis of the knee (at least grade 1 according to the Ahlbäck classification,5 see bmj.com). Criteria for exclusion were previous treatment with acupuncture; contraindication to medication with diclofenac; inflammatory, metabolic, or neuropathic arthropathies; severe concomitant illnesses that might interfere with the clinical evaluation of the patient; severe or generalised dermopathy; pregnancy or existing treatment with antineoplasic, corticoid, or immunosuppressive drugs.
We assigned the patients randomly to an intervention group treated with acupuncture plus diclofenac, and a control group given placebo acupuncture plus diclofenac.
Treatment applied
Pharmacological
The patients in both groups received a bag with 21 tablets (50 mg) of diclofenac for the week (50 mg to be taken every 8 hours) and the instruction to reduce the dose if symptoms improved.
True and placebo acupuncture
A doctor specialising in acupuncture (accredited by the Beijing University of Medical Sciences (China) and by the Scientific Society of Medical Acupuncture (ACMAS Huangdi, Spain)) selected acupuncture points on the basis of traditional treatment methods found to be effective for osteoarthritis of the knee (see bmj.com).6
7 The treatment lasted 12 weeks, starting with visit 0 and ending with visit 11. The doctor carried out the final evaluation at visit 12, one week after the treatment had ended.
The same specialist carried out the placebo acupuncture, at the same frequency and for the same duration as for the group receiving the true intervention. Retractable needles went into small adhesive cylinders, such that the needle was supported but did not perforate the skin.8 The acupuncturist then placed the needles over the same points as were used for the true acupuncture group.
Efficacy end points
We used as the primary efficacy end point the WOMAC index9 and its three subscales (pain (0-20), stiffness (0-8), and physical function (0-68)), pain in the knee on a visual analogue scale from 0 to 100, the dosage of diclofenac accumulated, and the profile of quality of life in the chronically ill (PQLC) instrument.10
Analysis
We analysed the results by intention to treat. For patients who withdrew, the score we used for each variable was the worst of the scores obtained for the intervention group and the best obtained for the control group. When a diagnosis of bilateral osteoarthritis of the knee had been made, the knee with the worst results at baseline was the knee we evaluated in the final analysis.
|
The WOMAC index presented a greater, and significant, reduction in the intervention group than in the control group (mean difference 23.9, 95% confidence interval 15.0 to 32.8); the magnitude of the reduction was greater in the subscale of functional activity (17.5, 11.0 to 24.0). The same result was observed in the pain visual analogue scale (reduction 26.6, 18.5 to 34.8). A reduction of 53.9 was observed in the total accumulated number of diclofenac tablets for the intervention group compared with the control group (24.7 to 83.1). The PQLC results indicate that acupuncture treatment produces significant changes in physical capability and psychological functioning (table 2).
|
According to the criterion that an improvement in quality of life requires changes in at least two of the variables measured by the PQLC, the acupuncture provided to the intervention group was more effective than the placebo treatment in improving patients' quality of life.
Limitations of the study
Observation of the sample groups over a period of 12 weeks may be insufficient to evaluate the effects of treatment in the medium term. Moreover, we did not test the patients' awareness of belonging to one or the other group, and so their complete "blindness" cannot be assured. Another possible limitation was the absence of techniques to verify the behaviour of the therapist, although the time spent with each patient was recorded; this was always close to the mean value (29.4 minutes).
Taking into account the duration of the study (12 weeks), we recorded patients' body mass index at the beginning and the end of the study, to evaluate the possible confounding effect of weight loss or gain. We found no significant differences.
We used different measurement techniques to evaluate the results obtained, testing whether the changes were all in the same direction and checking the consistency of the efficacy end points. We decided to use the categorical version of the WOMAC index because of the low cultural level of the population in the study area, and Spain's index of quality of life (PQLC) as a valid test for chronically ill patients. We considered the "total accumulated consumption of diclofenac" an objective variable with which to measure the responses of the two sample groups. As osteoarthritis is still an incurable illness, treatment is fundamentally aimed at improving the patient's quality of life, which is why we included this variable in the study. The consistency of the results is endorsed by the fact that the different aspects of physical functioning improved, according to both indices, the WOMAC and the PQLC. It is noteworthy that the evaluators were unaware of the group to which the patient had been assigned.
Comparison with other studies and outlook
The studies published to date have methodological deficiencies in the description and application of the method chosen for randomisation, the concealment of the treatment assignation scheme, the homogeneity of the groups to be compared, the control of co-interventions, the lack of control over participants' compliance with medical instructions, and the "blinding" of patients and evaluators. The heterogeneity of follow up periods was high.11-14 We attempted to improve on the methodological design of previous work, using a controlled, single blind, randomised trial with evaluation and analysis by third parties; the sample size was appropriate, and we controlled for possible confounding factors to a suitable degree; the professionals involved were suitably qualified; the placebo was adequately chosen; and the quality control of the materials used was ensured. We put particular emphasis on ascertaining the patient's sensation of Deqi when acupuncture was applied, and on describing secondary effects and the success of the technique in improving the patient's quality of life (PQLC).
|
Similar results were found in a small, short term and long term study, carried out by using the waiting list as the control group,11 and in another study that compared acupuncture plus baseline treatment with baseline treatment alone.12 In these studies, the absence of a placebo was a serious limitation to the validity of the conclusions; a third study incorporated a placebo, but in a hospital environment considered to be of low quality,4 whereas treatment was of greater intensity and duration of treatment was shorter.13 Another study compared acupuncture with sham acupuncture and found no statistically significant differences.14
Future research should extend the observation period after treatment in order to evaluate the duration of the improvement obtained and to establish treatment protocols.
This is the abridged version of an article that was posted on bmj.com on 19 October 2004: http://bmj.com/cgi/doi/10.1136/bmj38238.601447.3A
We thank M J Cano, J G de Hoyos, E Bassas, and C Andrés for their work in the conduct of the study, and J G de Hoyos for his useful comments on the initial protocol.
Funding: This study was partly financed by Servicio Andaluz de Salud (Grant No 192/99). The acupuncture materials and the drugs used in the study were provided by the Sevilla-Sur health district authorities.
Competing interests: None declared.
Ethical approval: Valme Hospital Ethics Committee, Seville.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Read all Rapid Responses